Vuzix Corporation (NASDAQ:VUZI) announced that Osaka Saiseikai Izuo Hospital in Osaka, Japan is using its Vuzix M400 smart glasses to provide remote medical support within the hospital's infectious zone areas.
"With their high-performance specs, all-day wearability, and hands-free operation, Vuzix smart glasses are tailor-made for use within hospitals and for telemedicine in general," said Vuzix CEO Paul Travers in a statement.
"We are seeing more and more doctors and hospitals and around the world testing and adopting our smart glasses and we look forward to working further with customers like Osaka Saiseikai Izuo Hospital to make their day-to-day operations safer and more productive."
READ: Vuzix strikes partnership with Icona Srl to provide remote assistance to manufacturing industry
Within the hospital's inpatient ward for patients with infectious diseases, zoning is used to divide the area into pathogen contaminated (red zone) and uncontaminated sanitary (green zone), Vuzix said.
Health care professionals need to wear personal protective equipment when going into the red zone. The hospital was able to function efficiently with a limited number of staff members working within the red zone by using Vuzix smart glasses running the Zoom application to remotely convey information vocally and visually, as well as to receive instructions.
The company noted that one use case is supporting the ability to double-check the medications and treatments used in the red zone by communicating with the doctors and medical staff located in the green zone. Another is remotely supporting the operation and the problems related to using advanced medical equipment. In this instance, clinical engineers would be able to participate in treatments remotely while operating advanced medical equipment, such as mechanical ventilators and extracorporeal membrane oxygenators (ECMO).
Additionally, Vuzix said the hospital believes that the glasses can be used not only within its infectious ward but also in a wider variety of areas including education and telemedicine.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham